Viva Biotech Holdings (HKG:1873)
Hong Kong · Delayed Price · Currency is HKD 1.305
-0.045 (-3.33%)
Oct 22, 2026, 4:08 PM HKT
Viva Biotech Holdings Market Cap
Viva Biotech Holdings has a market cap or net worth of 2.71 billion as of October 21, 2026. It is the 17,080th most valuable company in the world and the 750th biggest in Hong Kong. Its market cap has decreased by 49.80% in one year.
Market Cap
2.71B
Enterprise Value
2.57B
Revenue
2.20B
Global Rank
Country Rank
#750 Hong Kong
PE Ratio
16.42
ChartMarket Cap Chart
Since May 9, 2019, Viva Biotech Holdings's market cap has decreased from 6.63B to 2.71B, a decrease of -59.12%. That is a compound annual growth rate of -11.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 2.71B | -28.65% |
| Dec 31, 2025 | 3.80B | 109.02% |
| Dec 31, 2024 | 1.82B | -19.19% |
| Dec 29, 2023 | 2.25B | -32.91% |
| Dec 30, 2022 | 3.35B | -62.94% |
| Dec 31, 2021 | 9.04B | -48.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanx Biopharmaceuticals (Wuhan) | 3.68B |
| Mirxes Holding Company | 3.66B |
| Qyuns Therapeutics | 3.62B |
| Beijing Luzhu Biotechnology | 3.04B |
| Shanghai Bao Pharmaceuticals | 2.97B |
| Medtide | 2.79B |
| Laekna | 2.68B |
| Frontage Holdings | 2.67B |